Introduction You hear the words "glioblastoma" and the statistics hit immediately. Most people with this type of brain cancer survive for less than 2 years. Standard radiation and temozolomide chemotherapy can buy time, but the tumor nearly always returns. That grim reality is what makes the shift toward personalized immunotherapy matter in 2026. Instead of a one-size-fits-all poison, researchers now engineer treatments that match your tumor's specific genetic mutations, trai

Leukemia relapse after chemotherapy affects approximately 40-50% of younger adults and the majority of elderly patients with acute myeloid leukemia, but multiple effective treatment pathways now exist including salvage chemotherapy, targeted therapy, CAR-T cell therapy, and stem cell transplantation. TL;DR Yes, treatment is available when leukemia relapses after chemotherapy, with options including salvage chemotherapy, targeted therapy, CAR-T cell therapy, and stem cell tran